California Governor vs Chevron Debate Over Branded Gas Value Heats Up SpaceX Scrubs Starship V3 Test Flight Reschedules for Friday IPO Filing Reveals 15 Billion Program Cost Nios LongTerm Growth Potential Possibility of Doubling by 2029 CoveredCall ETF MSTY Limited Upside Potential Full Downside Exposure States Escalate Legal Battle Against Prediction Markets as Regulatory Clash Intensifies Anthropic Cofounder Chris Olah Warns Vatican on AI Job Losses Calls for Moral Oversight SPIR Q1 2026 Earnings EPS Misses Estimates as Stock Surges 1224 AVR Q1 2026 Earnings Wider Than Expected Losses as PreRevenue Biotech Advances JACK Q1 2026 Earnings EPS Misses by a Hair as Stock Rises 176 ZTO Q1 2026 Earnings Strong EPS Reported Amid Limited Disclosures MGTX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline MNST Q1 2026 Earnings Earnings Beat Estimates as EPS Surprises 833 Lexaria Bioscience LEXX Surges 733 as Biotech Momentum Builds Key Levels in Focus Evaxion EVAX Edges Higher Amid Biotech Sector Volatility Support and Resistance Levels in Focus Pitney Bowes PBI Edges Higher as Stock Holds Key Support Zone Berto Acquisition Corp TACO Edges Higher Amid Quiet Trading Support and Resistance Levels in Focus Graham Corporation GHM Holds Near Support as Slight Decline Tests Key Levels MTX Q1 2026 Earnings EPS Beats Estimates by 887 as Shares Edge Higher Grand Canyon Education LOPE Q1 2026 Earnings EPS Slightly Beats Estimates Shares Edge Higher PLG Q4 2023 Earnings NarrowerThanExpected Loss Amid Exploration Progress CYCN Q4 2025 Earnings Narrowed Losses Exceed Expectations as Development Programs Progress PLX Q1 2026 Earnings Massive EPS Surprise as Protalix BioTherapeutics Reports Strong Profitability Lucid Diagnostics Inc Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Diagnostics Firm Advances Product Commercialization Vickers Top Insider Picks Signal Potential Confidence Amid Market Volatility FOXF Q1 2026 Earnings EPS Beats Estimates by 1153 Amid Cost Discipline Permian Resources Holds Steady After Minor Decline Key Levels in Focus